AR054048A1 - Compuesto de 2- amino-4-oxo-1,3-tiazol-5- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del mismo para preparar un medicamento - Google Patents
Compuesto de 2- amino-4-oxo-1,3-tiazol-5- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del mismo para preparar un medicamentoInfo
- Publication number
- AR054048A1 AR054048A1 ARP060102092A ARP060102092A AR054048A1 AR 054048 A1 AR054048 A1 AR 054048A1 AR P060102092 A ARP060102092 A AR P060102092A AR P060102092 A ARP060102092 A AR P060102092A AR 054048 A1 AR054048 A1 AR 054048A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- prepare
- substituted
- oxo
- amino
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000002131 composite material Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 7
- -1 -OH Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- DQAIZGWCKXJRSP-UHFFFAOYSA-N 2-tert-butyl-1,3-thiazole Chemical group CC(C)(C)C1=NC=CS1 DQAIZGWCKXJRSP-UHFFFAOYSA-N 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000925 erythroid effect Effects 0.000 abstract 1
- 210000000777 hematopoietic system Anatomy 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos de 2-amino-4-oxo-1,3-tiazol-5-substituido de formula (1) en la que R se selecciona entre: arilo y arilo sustituido; y Q es como se muestra en la formula (2) donde A se selecciona entre CH y N; con la condicion de que cuando R es como en formula (3) R1 no es H, halogeno, -alquilo C1-6, -S-alquilo C1-6,.-O-alquilo C1-6, -NO2, -S(=O)-alquilo C1-6, -OH, -CF3, -CN, -CO2H, -OCF3 o -CO2-alquilo C1-6, cuando R2 y R3 se seleccionan, independientemente entre : H, halogeno, -alquilo C1-6, -S- alquilo C1-6,.-O-alquilo C1-6, -NO2, -S(=O)-alquilo C1-6, -OH, -CF3, -CN, -CO2H, -CO2-alquilo C1-6, -CONH2, -NH2, -OCH2(C=O)OH, -OCH2CH2OCH3, -SO2NH2, -CH2SO2CH3, -NH(C=NH)CH3, o como en los restos de formulas (4) con la condicion adicional de que R no es naftilo y con la condicion adicional de que R no es t-butiltiazol. Composicion farmacéutica que lo comprende y proceso para prepararla. Uso para preparar un medicamento para inhibir las proteínas hYAK3 y para tratar o prevenir enfermedades asociadas con la actividad hYAK3, como de los sistemas eritroide o hematopoyético.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68375205P | 2005-05-23 | 2005-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054048A1 true AR054048A1 (es) | 2007-05-30 |
Family
ID=37452631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060102092A AR054048A1 (es) | 2005-05-23 | 2006-05-22 | Compuesto de 2- amino-4-oxo-1,3-tiazol-5- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del mismo para preparar un medicamento |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090203692A1 (es) |
| EP (1) | EP1885362A4 (es) |
| JP (1) | JP2008545690A (es) |
| AR (1) | AR054048A1 (es) |
| PE (1) | PE20070006A1 (es) |
| TW (1) | TW200716579A (es) |
| UY (1) | UY29555A1 (es) |
| WO (1) | WO2006127458A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200716580A (en) | 2005-06-08 | 2007-05-01 | Smithkline Beecham Corp | (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one |
| US20100216801A1 (en) * | 2006-03-02 | 2010-08-26 | Dashyant Dhanak | Thiazolones for use as pi3 kinase inhibitors |
| CN103804312B (zh) * | 2014-02-17 | 2016-04-20 | 四川百利药业有限责任公司 | 一类氮杂环化合物及其制备方法和用途 |
| CN107721915A (zh) * | 2017-11-12 | 2018-02-23 | 刘磊 | 一种氯羟吡啶毒性杂质dcal的制备及纯化方法 |
| BR112020014593A2 (pt) * | 2018-01-18 | 2020-12-08 | Fmc Corporation | Processo para a síntese de sulfentrazona e processo para a preparação de uma sulfonamida de fórmula ii |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ539873A (en) * | 2002-11-22 | 2008-09-26 | Smithkline Beecham Corp | Novel chemical compounds, thiazolidin-4-one, thiazol-4-one |
| EP1718642A4 (en) * | 2004-02-25 | 2010-11-24 | Glaxosmithkline Llc | NEW CHEMICAL COMPOUNDS |
| RU2007103706A (ru) * | 2004-07-01 | 2008-08-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Хинолинтиазолиноны, обладающие cdk1-антипролиферативной активностью |
| EP1765817A1 (en) * | 2004-07-01 | 2007-03-28 | F.Hoffmann-La Roche Ag | Thiazolinone unsubstituted quinolines |
| US7241893B2 (en) * | 2004-09-17 | 2007-07-10 | Hoffman-La Roche Inc. | Thiazolinone 2-substituted quinolines |
| US7253285B2 (en) * | 2004-09-17 | 2007-08-07 | Hoffmann-La Roche Inc. | Thiazolinone 4-monosubstituted quinolines |
| US20100216801A1 (en) * | 2006-03-02 | 2010-08-26 | Dashyant Dhanak | Thiazolones for use as pi3 kinase inhibitors |
-
2006
- 2006-05-18 EP EP06770657A patent/EP1885362A4/en not_active Withdrawn
- 2006-05-18 US US11/912,965 patent/US20090203692A1/en not_active Abandoned
- 2006-05-18 WO PCT/US2006/019447 patent/WO2006127458A2/en active Application Filing
- 2006-05-18 JP JP2008513560A patent/JP2008545690A/ja active Pending
- 2006-05-19 UY UY29555A patent/UY29555A1/es unknown
- 2006-05-19 PE PE2006000532A patent/PE20070006A1/es not_active Application Discontinuation
- 2006-05-22 TW TW095118040A patent/TW200716579A/zh unknown
- 2006-05-22 AR ARP060102092A patent/AR054048A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1885362A4 (en) | 2010-09-22 |
| WO2006127458A2 (en) | 2006-11-30 |
| US20090203692A1 (en) | 2009-08-13 |
| WO2006127458A3 (en) | 2007-05-18 |
| PE20070006A1 (es) | 2007-01-31 |
| UY29555A1 (es) | 2006-11-30 |
| JP2008545690A (ja) | 2008-12-18 |
| TW200716579A (en) | 2007-05-01 |
| EP1885362A2 (en) | 2008-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021003012A1 (es) | Inhibidores del inflamasoma nlrp3 | |
| CL2022003510A1 (es) | Inhibidores de cisteína proteasas y sus métodos de uso | |
| UY38070A (es) | Derivados de quinazolina y piridopirimidina sustituidos útiles como agentes anticáncer | |
| UY29004A1 (es) | Compuestos derivados sustituídos de ácidos, glicina y alanina; procedimiento para su preparación y uso. | |
| NI201200184A (es) | Morfolinopirimidinas y su uso en terapia | |
| UY28482A1 (es) | Nuevos compuestos | |
| BR112017018643A2 (pt) | "derivados de tetra-hidrotiazepina bicíclicos úteis, composição farmacêutica compreendendo os mesmos, seu uso, e método in vitro ou ex vivo para a produção de células imunes ativadas" | |
| UY29079A1 (es) | Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| UY28990A1 (es) | Nuevos derivados de benceno 1, 3-amino carbonilo como inhibidores de b-raf, composiciones farmacéuticas que los contienen, procesos de preparación y uso. | |
| ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
| CL2004000917A1 (es) | Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa | |
| UY32483A (es) | Nuevos compuestos de bencimidazol para el tratamiento del virus sincicial respiratorio | |
| ECSP088975A (es) | Nuevos análagos de piridina | |
| UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
| UY29092A1 (es) | Derivados de 4-oxo-3,4-dihidroquinazolin-6-carboxamida, inhibidores de b-raf, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
| CR8778A (es) | Revestimientos de azucar y metodos para estos | |
| UY29818A1 (es) | Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos | |
| ECSP088821A (es) | Derivados de tioxantina y su uso como inhibidores de la mpo | |
| ECSP088288A (es) | DERIVADOS DE 7-(2-AMINO-1-HIDROXI-ETIL)-4-HIDROXIBENZOTIAZOL-2(3H)-ONA COMO AGONISTAS DE LOS ADRENOCEPTORES ß2 | |
| BR112014023384A8 (pt) | inibidores de bace espirocíclicos de di-hidro-tiazina e di-hidro-oxazina, e composições e usos dos mesmos. | |
| UY31885A (es) | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. | |
| UY31048A1 (es) | Nuevos compuestos de pirimidina y usos de los mismos | |
| UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
| UY27852A1 (es) | Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
| CO6382089A2 (es) | Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |